Highlighted
Notice of Extraordinary General Meeting
Sep 11, 2026
Notice of an Extraordinary General Meeting
Results for the Second Quarter & First Half 2026
Aug 21, 2026
Medistim delivers record first-half revenue and record EBIT in Q2 2026
Results for the First Quarter 2026
May 7, 2026
Medistim Passes MNOK 200 in Quarterly Sales for the First Time
Results for the Fourth Quarter and Full Year 2025
Feb 27, 2026
Record Sales and Strong Profit Growth in Q4 and Full Year
Medistim Opens a Direct Sales Office in Japan
Feb 3, 2026
Medistim ASA announced on February 3rd the opening of a direct sales operation in Japan, effective March 16, 2026.
Results for the Third Quarter and YTD September 2025
Oct 24, 2025
Medistim delivers another strong quarter, with solid growth and record sales year-to-date.
Results for the Second Quarter and First Half 2025
Aug 20, 2025
Another strong quarter for sales revenues with 16.7 % growth, ending at MNOK 169.1 (MNOK 144.9). Record sales revenue for the first half year with 25.8 % growth, ending at MNOK 350.6 (MNOK 278.7).
